Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In what way do you think it is more "exclusive" than the other 90?
In what way are we "exclusive" license? Which element of the Roswell portfolio is of particular interest to NWBO. Roswell is involved in a very broad research effort in treatment of cancer. Is this a synergy with DCVAX or just a door to some promising new research in cancer treatment?
From the Roswell Park website:
In fiscal year 2023....
$108.5M IN GRANTS & CONTRACTS
480 FUNDED RESEARCH PROJECTS
121 LICENSE AGREEMENTS
91 U.S. PATENTS
*Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property"
NWBO has been fairly astute in their purchases looking to the future. They see a bargain that van be useful and valuable to complement their portfolio and they go for it. They did this with the purchase of Sawston, and they did this again with the purchase of Flaskworks, and they are now hopefully doing the same with this deal with Roswell. The price is a reasonably low number of about $2mil and quite manageable for NWBO.
My only question is whether this is an appropriate time to prepare to expand further out, when they have much to do on their current and ONLY platform. Assuming that the current MAA will be successful, they still have an awful lot to keep them very busy in further expanding the current platform. They will need to initiate many trials using L in many other cancer indications. This will take time, effort and much money. They will also need to expand the platform with many clinical trial in many cancer indications using Direct. This too, will take time, effort and much money. Hopefully this platform becomes the next SOC, not just in GBM, but in all solid cancer. Hopefully the MAA and the spoofing trial will provide some of this cash to NWBO, but the cash spigot will not be at full flow right away - this will take some time to develop.
Do we now want to decrease our focus on the current platform, away from the many things to be done, to start to expend much time effort and money on newer fields of related research. I would think we go slowly on this and retain the significant focus on the DCVAX for cancer vaccine for the foreseeable future and not reduce out attention on the current prize of SOC in solid cancer. I do not mind the use of $2mil now to get a foot in the door on further advancements for the future and am hopeful that this will prove to be insightful and another worthy investment in the future of NWBO. I am glad that there is little focus by NWBO required or planned by NWBO for the immediate future so they can continue to focus on DCVAX and not need to spread their immediate attention too thin.
My minor modification:
1. Alaska - too cold
2. Tennessee - just perfect
3. New Hampshire - too many woke Demos'
4. Wyoming - very remote, that is why it remains beautiful.
5. Florida - too many hurricanes and far too humid in summer but great in winter
Then we are all in deep doo doo!
I miss your posts. What was your offense to limit you to one post a day. For how long? Who decides these punishments?
So why are they not already buying now - why wait? Early bird gets the worm.
I had respect for your posts - until this post today!
you are unreal - that was tongue in cheek!!
and 1.7 billion outstanding shares
If they were notified of approval before the open tomorrow, the question might be, do they announce it immediately, or better plan how they're doing it a day, or two later.
At one time I had hoped NWBO had asked for more than just nGBM and RGBM, but they've stated several times that's all it is, so I have to believe them.
No doctor will prescribe it to a cancer other than gbm
Option 1 (receipt of MAA) doesn't guarantee a valid application. The MHRA needs to first assess the application for completeness and compliance.
I think it's imperative that DCVax-L be approved on its own to sta
Northwest Bio also seems well prepared for the manufacturing and clinical trial site visits that occur in the second phase of assessment.
Reviewed 10q yet again to see why (a day b/4 10q came out) Les thought it might refer to a fall maa decision timeline,
Choice of either the magistrate or the judge continuing with the spoofing case by May 21, 2024 - technically it is from the Co's lawyer.
He can't front run regulators by saying "next week"
Flipper, I think what is more likely is given that the MAA submission was extremely large (1.7 Mil) and therefore the first phase of the MHRA analysis took longer than the normal time, and there was only one RFI without NWBO asking for an extension, and this can still be called "on the 150 day track" even though it took the MHRA a little longer to do the analysis. So everything is going well as per Les om Biz
Makes sense to me.
Of course we all could be wrong about how long it will take for off label use covered by insurance if the data from off label use in the compassionate use in the UK were released and made many oncologists realize that they should be using DCVax-L now with their patient with a variety of solid cancers. I don't know if such data will ever be released, and what it will show if it is,
it could easily take a decade or longer,
The fact that they have not yet been scheduled as of 3/31 is simply to raise concern about making the 150-day target.
it seems that additional MHRA inspections are still
pending and have not yet been scheduled. Also apparently
in preparation for those inspections, the company is arranging
for additional mock inspections.
I do not frequent bars!
Yes, he can do that IF HE IS PRESIDENT - EVEN IF HE IS IN PRISON.
I believe tomorrow is the day - at any time they choose.
That is a ridiculous reach!
but I don't think that they can PR it.
The question was why would either side prefer the magistrate rather than the judge to continue on the case?
Should be out on Friday.
I agree with you that this had been debated at length. I too thought that calendar days were meant, and most of us so assumed. I am now hearing that it is business days.
CVM and NWBO are pees in a pod.
So we are 140 days from submission . Let’s see who is still singing praises for the new earth shattering initiatives of MHRA for fast approval esp in area of unmet and critical needs . Even if they approve tomorrow they barely will meet 150 day deadline
He obviously meant selling as president on behalf of NWBO to investors, such as for warrant exercise and PP. He did not mean selling her own shares in NWBO.
will put NWBO and partners on a logarithmic trajectory.
If a non friendly transaction occurs then those unaccounted for shares don’t get covered but rather get “discovered” as not existing leaving investors with a potentially very big loss.